New data provided by Michelle Lowes and colleagues at The Rockefeller University, New York, has provided a detailed characterization of the immune sentinel cells in the normal human skin.
Get the full story...
Green tea is already touted for its cancer-fighting properties. A new study finds that it may also hold promise in treating inflammatory skin conditions such dandruff, lupus-induced lesions and psoriasis.
Get the full story...
Green tea could hold promise as a new treatment for skin disorders such as psoriasis and dandruff, Medical College of Georgia researchers say.
Get the full story...
A research team at the Swedish medical university Karolinska Institutet has shown for the time that microRNA, small RNA molecules, may play an important role in the development of inflammatory skin diseases such as psoriasis and atopic eczema. The research team is led by Professor Mona Stеhle, one of Sweden’s most prominent scientists in the field.
Get the full story...
The body may hold a secret to normalizing skin cell growth that is over zealous in psoriasis and non-melanoma skin cancers and too slow in aging and sun-damaged skin, researchers say.
Get the full story...
An important finding, which could eventually lead to a new therapeutic approach for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and others, was announced today by researchers at the La Jolla Institute for Allergy & Immunology (LIAI).
Get the full story...
Findings from an integrated analysis of data from three pivotal, randomized, placebo-controlled trials showed that at week 10 more than three-quarters of patients with severe psoriasis receiving REMICADE® (infliximab) 3 mg/kg or 5 mg/kg achieved a 75 percent improvement in the chronic, inflammatory skin disease as measured by the Psoriasis Area Severity Index (PASI 75).
Read the full story
The National Psoriasis Foundation and Amgen (NASDAQ: AMGN), today announced survey findings which show that nearly 40 percent of 1,142 patients surveyed with chronic moderate or severe psoriasis are not currently receiving any treatment. These results were presented at the American Academy of Dermatology (AAD) Scientific Meeting in Washington, D.C.
Read the full story